M. Zasadzińska and G. Borowski, “Semaglutide as a promising treatment for metabolic dysfunction‑associated steatotic liver disease”, JMS, vol. 94, no. 1, p. e1219, Mar. 2025, doi: 10.20883/medical.e1219.